Inhibition of bovine peripheral blood mononuclear cell blastogenesis by fractionated mammary secretion

1. Bovine mammary secretion whey obtained during late involution markedly inhibited mitogen-induced blood mononuclear cell blastogenesis. 2. Whey proteins eluting in the first and second absorbance peaks following molecular exclusion chromatography were associated with greatest inhibition of mononuclear cell blastogenesis. 3. Greatest inhibition of concanavalin A-stimulated mononuclear cell blastogenesis was associated with high concentrations of whey proteins in absorbance peak 1. 4. Whole mammary secretion whey and whey proteins in absorbance peak 2 caused similar inhibition of concanavalin A- and phytohaemagglutinin-treated mononuclear cells. 5. Differential inhibition of mitogen-induced blastogenesis may reflect the presence of immunosuppressive substances in bovine mammary secretion whey which differ in specificity for bovine T-cell subsets.     

The 24p3 gene is induced during involution of the mammary gland and induces apoptosis of mammary epithelial cells

To understand the molecular mechanism of mammary gland involution we identified involution-induced clones by differential screening of a mouse mammary gland cDNA library. Characterization of clones by sequencing and Northern analysis showed that expression of 24p3 was induced during involution of the mammary gland. RNA in situ hybridization showed that it was mainly expressed in the secretory epithelial cells surrounding the lumen of the mammary gland alveoli. Induction of 24p3 was also observed in apoptotic HC11 mammary epithelial cells under serum starvation. In these cells, dexamethasone increased 24p3 gene expression four-fold. Transient expression of 24p3 increased the percentage of apoptotic cells 3- to 4-fold over a period of 3 days after transfection. This study provides evidence that overexpression of 24p3 gene can induce apoptosis of mammary epithelial cells.     

Species-specific cell-matrix interactions are essential for differentiation of alveoli like structures and milk gene expression in primary mammary cells of the Cape fur seal (Arctocephalus pusillus pusillus).

Few models are in place for analysis of extreme lactation patterns such as that of the fur seals which are capable of extended down regulation of milk production in the absence of involution. During a 10-12 month lactation period, female fur seals suckle pups on shore for 2-3 days, and then undertake long foraging trips at sea for up to 28 days, resulting in the longest intersuckling bouts recorded. During this time the mammary gland down regulates milk production. We have induced Cape fur seal (Arctocephalus pusillus pusillus) mammary cells in vitro to form mammospheres up to 900 microm in diameter, larger than any of their mammalian counterparts. Mammosphere lumens were shown to form via apoptosis and cells comprising the cellular boundary stained vimentin positive. The Cape fur seal GAPDH gene was cloned and used in RT-PCR as a normalization tool to examine comparative expression of milk protein genes (alphaS2-casein, beta-lactoglobulin and lysozyme C) which were prolactin responsive. Cape fur seal mammary cells were found to be unique; they did not require Matrigel for rapid mammosphere formation and instead deposited their own matrix within 2 days of culture. When grown on Matrigel, cells exhibited branching/stellate morphogenesis highlighting the species-specific nature of cell-matrix interactions during morphological differentiation. Matrix produced in vitro by cells did not support formation of human breast cancer cell line, PMC42 mammospheres. This novel model system will help define the molecular pathways controlling the regulation of milk protein expression and species specific requirements of the extracellular matrix in the cape fur seal.     

Cytokines involved in the immunosuppressor period in experimental fasciolosis in rats

The aim of this study was to evaluate the kinetics of the cytokines interferon-gamma, interleukin-2, interleukin-10 and interleukin-4 produced by spleen mononuclear cells stimulated by Con A during an experimental infection in rats with Fasciola hepatica. The proliferative response to Con A of Spm cells from rats infected with F. hepatica was significantly decreased on day 7 post-infection (P<0.006) and simultaneously an increase of interferon-gamma, interleukin-10 and interleukin-4 production along with a decrease of interleukin-2 by spleen mononuclear cells were observed. Interleukin-4 and interleukin-10 were involved in ablating cellular proliferation in vitro, as the addition of neutralising antibodies to either cytokine reversed the proliferative block. The addition of exogenous recombinant interleukin-2 also restored the proliferative response by spleen mononuclear cells obtained 7 days after infection from infected rats. At the same time, we found an increase in interleukin-10 production by peritoneal cells (in close contact with the flukes) and decreased nitric oxide levels. In addition, histological studies on the liver on day 7 after infection showed the presence of parasite inside migratory tunnels in the parenchyma, and polymorphonuclear leukocytes, predominantly eosinophils, around the parasite. The transient suppression in proliferative response mediated by cytokines interleukin-4 and interleukin-10 in the spleen, and diminution of nitric oxide production in the peritoneum could be mechanisms to evade the protective immune response during the first stages of liver penetration by the parasite.     

Reactive oxygen species initiate luminal but not basal cell death in cultured human mammary alveolar structures: a potential regulator of involution

Post-lactational involution of the mammary gland is initiated within days of weaning. Clearing of cells occurs by apoptosis of the milk-secreting luminal cells in the alveoli and through stromal tissue remodeling to return the gland almost completely to its pre-pregnant state. The pathways that specifically target involution of the luminal cells in the alveoli but not the basal and ductal cells are poorly understood. In this study we show in cultured human mammary alveolar structures that the involution process is initiated by fresh media withdrawal, and is characterized by cellular oxidative stress, expression of activated macrophage marker CD68 and finally complete clearing of the luminal but not basal epithelial layer. This process can be simulated by ectopic addition of reactive oxygen species (ROS) in cultures without media withdrawal. Cells isolated from post-involution alveoli were enriched for the CD49f⁺ mammary stem cell (MaSC) phenotype and were able to reproduce a complete alveolar structure in subcultures without any significant loss in viability. We propose that the ROS produced by accumulated milk breakdown post-weaning may be the mechanism underlying the selective involution of secretory alveolar luminal cells, and that our culture model represents an useful means to investigate this and other mechanisms further.     

乳腺重构的过程及其调节因素

受到妊娠周期的影响，乳腺组织在雌性哺乳动物一生中经历着妊娠-哺乳-退化的周期性发育变化. 在乳腺退化到再次泌乳的过程中，乳腺细胞经历凋亡和更新，从而实现乳腺组织的自我更新和修复，即乳腺重构. 重构期间乳腺在组织结构和生理过程中发生显著变化，但该过程物种间差异较大. 乳用家畜为维持泌乳，妊娠期和干奶期重叠，展示出独特的再生性乳腺重构. 再生性乳腺重构对乳畜乳腺健康和下一周期的泌乳具有重要意义，研究此过程将为后续调控乳腺自我更新和改善乳腺健康提供思路. 本综述总结了近年来动物乳腺重构的研究进展，系统归纳了影响乳腺重构的因素，包括激素、蛋白酶、细胞因子、热应激、氧化应激、光照周期等，旨在解析乳腺重构的生理机制，为精准调控该过程提供科学依据.     

Enzyme Histochemistry as a Link between Biochemistry and Morphology

A study has been made of the progress of involution of the mouse and rat mammary gland using histologic, electron microscopic, histochemical and autoradiographic methods. Particular emphasis has been placed on the morphology, metabolic alte-rations and activities of histochemically identifiable enzymes, and on the pharmacologic effects of lactation inhibiting agents and cytostatic drugs on lactation and involution. In order to allow a systematic investi-gation, involution was initiated in rats and mice by ligation of individual gland ducts at various time intervals. Both lactating glands and glands in different phases of involution were thus available in a given animal.The most important observation was that involution, which altogether takes approximately 2 weeks to be complete, involves a three-phase process, each phase being clearly distinguishable by morphologic and histochemical criteria. The first phase comprises approximately 4 days during which production of milk may be reinitiated. The second phase starts on day 5 of involution and constitutes the period of involution per se characterized by appreciable parenchymal cell degradation. The third phase, which starts around day 10, is the period of reorganization to the resting mammary gland.Early in the first phase of involution, substantial alveolar enlargement due to engorgement with milk, together with epithelial flattening, are prominent features. By day 3, the glandular contents decrease again in volume, the number of glandular cells and the constituent cytoplasmic organelles remaining unchanged during this period, except for the diminished appearance of fat droplets. In addition to normal appearing vacuoles with only occasional or sparse protein granules, giant vacuoles containing, in part, several hundred casein granules are found. Their formation appears to be due to increased stacking of granules in distended vacuoles prior to dissociation from the Golgi apparatus. In addition, however, the enhanced reactions of a1P (alkaline phosphatase) and ATPase, which are found in the apical plasmalemma, are suggestive of resorptive activities. Protein particles absorbed from the glandular lumen equally appear to have a capacity for fusing into large vacuoles. The large protein granule-containing vacuoles regularly exhibit intense (3-Glu activity. This enzyme would appear to contribute actively to the degradation of excess milk during the first phase of involution.Autoradiographic studies reveal that the synthesis and release of proteins into the secretion is maintained for 3 days. While 3H-tyrosine uptake by the alveolar cells continues unchanged, the incorporation of 3H-palmitic acid into glandular lipoids, and of 3H-fucose into glandular polysaccharides is virtually blocked completely. An immediate reaction of the lipoid metabolism is also indicated by the decrease in 3HBDH activity on the first day of involution.The activities of the histochemically detected oxidoreductases (LDH, MDH, SDH, G6PDH, 3HBDH) show a sharp fall on day 1 of involution, reaching levels approximately one half of the activity observed during lactation, as shown on micro densitometry. The activities remain unchanged during the following 4 days.No degradation of glandular parenchyma is noted during the-first phase of involution. The glandular cells rather take a -wait-and-see- attitude which enables them to participate again in the secretion of milk, as need arises. At this time the activities of the enzymes implicated in energy metabolism have reached approximately the resting mammary gland level. Only protein synthesis is maintained virtually unrestricted and this results in the production of excess milk constituents that are degraded as soon as they are being formed.In the second phase of involution, large seg-ments of the glandular epithelium undergo invo-lution, a process which involves the destruction of glandular epithelial cells and the removal of the resulting cellular debris from the mammary gland. The glandular cells remaining are transformed into resting cells. The lysosomes of the glandular epithelial cells, with maximum numbers being attained between days 7 to 9, contribute decisively to this degradative process. Ultra-structurally, this stage is initially characterized by the appearance in the alveolar cell cytoplasm of segregated cytoplasmic areas which stain negatively for acP (acid phosphatase) and are rich in organelles. These cytoplasmic areas change to membrane-bordered lysosomes which possess intense acP activity. The lysosomes are obviously required for the autophagic degradation of cytoplasmic segments. At the same time the activities of other lysosomal enzymes, involving acP, N-A-Gase, AMPase and AS, show a sharp increase. ATPase and TPPase likewise exhibit considerably increased activity during the second phase of involution. It is seen on microdensitometry that during this phase the acP attains approximately three times the lactation activity. In contrast, the activity of (3-Glu, after having shown a very high increase during the first phase, reverts again to the resting mammary gland level.During the second phase of involution, the oxidoreductases are subject to a further drastic decline of their activities. This process, which consistently affects all segments of the mammary gland,,comes to completion within a few hours. The reaction is found to be minimal around day 5 of involution, at a time when the enzyme activities are approximately one quarter of the lactation levels.At this time, many alveolar cells are destroyed and released into the glandular lumen, the acP retaining its activity in the lysosomes of sloughed cells or cell debris. The resulting gaps in the alveolar epithelium are either bridged immediately or remain detectable on histology. Yet the glandular contents do not pass into the interstitial tissue. The adherence of the glandular tree and the glandular epithelium is ensured by myoepithelial cells. The basement membrane effects the complete segregation of the parenchyma from the interstitial tissue:Macrophages which at this stage occur increa-singly near the alveoli, in the alveolar epithelium and in regional lymph nodes, and which are conspicuous due to numerous acP-laden lysosomes participate essentially in glandular regression.The third phase of involution, which takes place approximately 10 to 14 days following the onset of milk stasis, is the period of reorganization to the resting mammary gland, a period during which glandular cells containing little cytoplasm and sparse organelle lining make their appearance. However, the activities of acP and other lysosomal enzymes remain elevated compared to the pregestational level. Histochemically, the reaction of the oxidoreductases is more intense than during the second involutionary phase, corresponding roughly to the level of the mammary gland in the resting state. The formation of the glandular epithelial cells of the resting mammary gland is not due to renewed mitotic activity, but results from the reduction of actively secreting epithelial cells.Throughout the period of involution the myo-epithelium consistently changes its shape. How-ever, cytoplasmic alterations are not discernible on electron microscopy, nor do these cells undergo degradation during glandular involution. The alP reaction is of particular value for the identification of the myoepithelial cells. No alteration in enzyme activities is demonstrable at the histochemical level throughout the process of involution.Alterations in the interstitial tissue affect particularly the adipose tissue. During lactation, the interalveolar space exhibits only a narrow connective tissue layer which changes insignificantly during the first phase of involution, whereas the subsequent incorporation of lipids results in the formation of plurilocular lipid cells and the reappearance of unilocular adipose tissue as involution advances. During this period the vessels move away from the alveoli.The response of the mammary gland to lactation inhibiting and cytostatic drugs varies, depending on the agent administered. Estrogencontaining drugs lead to an involutionary process which in its initial phase differs from that observed during normal glandular regression. Due to the fact that the milk continues to be suckled by the young, milk production however ceasing very rapidly, the (3-Glu activity is not found to increase greatly during the first phase of involution. The behavior of the lysosomal enzymes during the second phase resembles that seen during normal involution.After administration of the ergot alkaloid 2-Br-a-ergokryptine methane sulfonate (CB 154), the process of involution is initiated only in individual mammary gland cells if the young are left with the mother. In these areas involution takes a normal course. Altogether, milk production changes only insignificantly.The cytostatic drug 5-fluorouracil does not induce direct involution. Milk production apparently is not arrested. However, the pups, when left with the mother, die after 5 to 6 days. Death would appear to be due to the cytotoxic action of 5-fluorouracil.     

Proteinases of the mammary gland: developmental regulation in vivo and vectorial secretion in culture.

The extracellular matrix (ECM) is an important regulator of mammary epithelial cell function both in vivo and in culture. Substantial remodeling of ECM accompanies the structural changes in the mammary gland during gestation, lactation and involution. However, little is known about the nature of the enzymes and the processes involved. We have characterized and studied the regulation of cell-associated and secreted mammary gland proteinases active at neutral pH that may be involved in degradation of the ECM during the different stages of mammary development. Mammary tissue extracts from virgin and pregnant CD-1 mice resolved by zymography contained three major proteinases of 60K (K = 10(3) Mr), 68K and 70K that degraded denatured collagen. These three gelatinases were completely inhibited by the tissue inhibitor of metalloproteinases. Proteolytic activity was lowest during lactation especially for the 60K gelatinase which was shown to be the activated form of the 68K gelatinase. The activated 60K form decreased prior to parturition but increased markedly after the first two days of involution. An additional gelatin-degrading proteinase of 130K was expressed during the first three days of involution and differed from the other gelatinases by its lack of inhibition by the tissue inhibitor of metalloproteinases. The activity of the casein-degrading proteinases was lowest during lactation. Three caseinolytic activities were detected in mammary tissue extracts. A novel 26K cell-associated caseinase--a serine arginine-esterase--was modulated at different stages of mammary development. The other caseinases, at 92K and a larger than 100K, were not developmentally regulated. To find out which cell type produced the proteinases in the mammary gland, we isolated and cultured mouse mammary epithelial cells. Cells cultured on different substrata produced the full spectrum of gelatinases and caseinases seen in the whole gland thus implicating the epithelial cells as a major source of these enzymes. Analysis of proteinases secreted by cells grown on a reconstituted basement membrane showed that gelatinases were secreted preferentially in the direction of the basement membrane. The temporal pattern of expression of these proteinases and the basal secretion of gelatinases by epithelial cells suggest their involvement in the remodelling of the extracellular matrix during the different stages of mammary development and thus modulation of mammary cell function.     

Expression of M-N#1, a histo-blood group B-like antigen, is strongly up-regulated in nonapoptosing mammary epithelial cells during rat mammary gland involution.

Antibodies against the histo-blood group B-like antigen M-N#1 efficiently block the growth in vivo of rat mammary carcinoma cells that bear the antigen (Sleeman et al., 1999, Oncogene 18, 4485--4494). To try to understand the function of the M-N#1 antigen, we investigated when and where the antigen is expressed during the normal function of the rat mammary gland. Expression was virtually only seen during mammary gland involution. Here, strong expression of the antigen was observed in mammary epithelial cells, beginning around 2 days postweaning and lasting throughout the involution process. Dexamethasone treatment of animals postlactation inhibited alveolar collapse and remodeling in the mammary gland but inhibited neither the apoptosis of mammary epithelial cells nor the expression of the M-N#1 antigen. We show that up-regulation of carbohydrate antigens is not a general phenomenon during mammary gland involution, and thus that M-N#1 antigen expression is specifically regulated. Up-regulation of alpha(1,2)fucosyltransferase A, an enzyme required for M-N#1 antigen synthesis, is at least partly responsible for regulated M-N#1 antigen expression postlactation. Most significantly, we observed that the M-N#1 antigen is virtually exclusively expressed on nonapoptosing epithelial cells in the involuting mammary gland. These data suggest that M-N#1 antigen expression might either provide a survival function and/or be expressed in epithelial cells that are destined to grow and remodel mammary duct structures.     

Secretion composition during bovine mammary involution and the relationship with mastitis

1. Bacteriological analysis revealed that 30% of quarters contained coagulase-negative staphylococci, Staphylococcus aureus, Corynebacterium bovis, or streptococci. 2. As involution progressed, somatic cell counts, percent protein, pH, and concentrations of serum albumin, lactoferrin, and immunoglobulin G increased while percent fat, concentrations of citrate, and the citrate to lactoferrin molar ratio decreased. 3. Mammary secretion from infected quarters had significantly higher numbers of somatic cells, percent polymorphonuclear leukocytes, and pH, but lower percentage lymphocytes, fat, and lactoferrin concentrations compared to uninfected quarters. 4. Results suggest intramammary infection altered normal secretion composition during bovine involution and lactogenesis. 5. Lower levels of antibacterial components in bovine mammary secretion during the peripartum period may have reduced the natural defense potential of the gland.     

Bovine CCL28 Mediates Chemotaxis via CCR10 and Demonstrates Direct Antimicrobial Activity against Mastitis Causing Bacteria

In addition to the well characterized function of chemokines in mediating the homing and accumulation of leukocytes to tissues, some chemokines also exhibit potent antimicrobial activity. Little is known of the potential role of chemokines in bovine mammary gland health and disease. The chemokine CCL28 has previously been shown to play a key role in the homing and accumulation of IgA antibody secreting cells to the lactating murine mammary gland. CCL28 has also been shown to act as an antimicrobial peptide with activity demonstrated against a wide range of pathogens including bacteria, fungi and protozoans. Here we describe the cloning and function of bovine CCL28 and document the concentration of this chemokine in bovine milk. Bovine CCL28 was shown to mediate cellular chemotaxis via the CCR10 chemokine receptor and exhibited antimicrobial activity against a variety of bovine mastitis causing organisms. The concentration of bovine CCL28 in milk was found to be highly correlated with the lactation cycle. Highest concentrations of CCL28 were observed soon after parturition, with levels decreasing over time. These results suggest a potential role for CCL28 in the prevention/resolution of bovine mastitis.     

Enhanced synthesis of gelatinase and stromelysin by myoepithelial cells during involution of the rat mammary gland.

During the involution of the mammary gland there is destruction of the basement membrane as the secretory alveolar structures degenerate. Immunofluorescence staining of sections of rat mammary gland with antibodies to 72 KD gelatinase (MMP-2) and stromelysin (MMP-3) revealed increased production of these two proteinases during involution. This increased expression was mostly restricted to myoepithelial cells. Increased expression during involution was also demonstrated by immunoblotting techniques. Gelatin zymography indicated that the predominant metalloproteinase present in involuting rat mammary glands was a 66 KD gelatinase.     

Coordinated expression of extracellular matrix-degrading proteinases and their inhibitors regulates mammary epithelial function during involution

Extracellular matrix (ECM) plays an important role in the maintenance of mammary epithelial differentiation in culture. We asked whether changes in mouse mammary specific function in vivo correlate with changes in the ECM. We showed, using expression of beta-casein as a marker, that the temporal expression of ECM-degrading proteinases and their inhibitors during lactation and involution are inversely related to functional differentiation. After a lactation period of 9 d, mammary epithelial cells maintained beta-casein expression up to 5 d of involution. Two metalloproteinases, 72-kD gelatinase (and its 62-kD active form), and stromelysin, and a serine proteinase tissue plasminogen activator were detected by day four of involution, and maintained expression until at least day 10. The expression of their inhibitors, the tissue inhibitor of metalloproteinases (TIMP) and plasminogen activator inhibitor-1, preceded the onset of ECM-degrading proteinase expression and was detected by day two of involution, and showed a sharp peak of expression centered on days 4-6 of involution. When involution was accelerated by decreasing lactation to 2 d, there was an accelerated loss of beta-casein expression evident by day four and a shift in expression of ECM-remodeling proteinases and inhibitors to a focus at 2-4 d of involution. To further extend the correlation between mammary-specific function and ECM remodeling we initiated involution by sealing just one gland in an otherwise hormonally sufficient lactating animal. Alveoli in the sealed gland contained casein for at least 7 d after sealing, and closely resembled those in a lactating gland. The relative expression of TIMP in the sealed gland increased, whereas the expression of stromelysin was much lower than that of a hormone-depleted involuting gland, indicating that the higher the ratio of TIMP to ECM-degrading proteinases the slower the process of involution. To test directly the functional role of ECM-degrading proteinases in the loss of tissue-specific function we artificially perturbed the ECM-degrading proteinase-inhibitor ratio in a normally involuting gland by maintaining high concentrations of TIMP protein with the use of surgically implanted slow-release pellets. In a concentration-dependent fashion, involuting mammary glands that received TIMP implants maintained high levels of casein and delayed alveolar regression. These data suggest that the balance of ECM-degrading proteinases and their inhibitors regulates the organization of the basement membrane and the tissue-specific function of the mammary gland.(ABSTRACT TRUNCATED AT 400 WORDS)     

Regulation of Autophagy in Bovine Mammary Epithelial Cells

The bovine mammary gland undergoes intensive remodeling during the lactation cycle, and the escalation of this process is observed during dry periods. The main type of cell death responsible for bovine mammary gland involution is apoptosis; however, there are also a lot of cells exhibiting morphological features of autophagy during drying off. Our in vitro and in vivo studies of bovine mammary gland physiology suggest that the enhanced process of autophagy, observed at the end of lactation and during dry periods, is the result of: (1) decreased level of lactogenic hormones (GH, IGF-I), (2) decreased GH-R and IGF-IRα expression, (3) increased expression of auto/paracrine apoptogenic peptides (IGFBPs, TGF-β1), (4) increased influence of sex steroids (17β-estradiol and progesterone) and (5) enhanced competition between the intensively developing fetus and the mother organism for nutritional and bioactive compounds. The above conditions may create a state of temporary malnutrition of mammary epithelial cells, which forces the cells to the induction of autophagy, as a mechanism for stabilizing intracellular supplies of energy and amino acids, especially during the enhanced activity of apoptogenic factors.

Addendum to:

Apoptosis and Autophagy in Mammary Gland Remodeling and Breast Cancer Chemotherapy

T. Motyl, B. Gajkowska, J. Zarzyńska, M. Gajewska and M. Lamparska-Przybysz

J Physiol Pharmacol 2006; 57:17-32     

Expression of nuclear hormone receptors, their coregulators and type I iodothyronine 5'-deiodinase gene in mammary tissue of nonlactating and postlactating rats

The aim of the study was to test the hypothesis that expression of retinoid receptors (RARalpha, RARbeta, RARgamma), rexinoid receptors (RXRalpha, RXRbeta), thyroid hormone receptors (TRalpha, TRbeta), estrogen receptors (ERalpha, ERbeta), nuclear receptor coregulators (N-CoR, SRC-1, SMRT), and in addition type I iodothyronine 5'-deiodinase (5'-DI), EGFR and erb-B2/neu would be different in mammary postlactating tissue in comparison with that of nonlactating mammary gland. Using RT-PCR, we have shown that expression of RARalpha, RXRalpha,TRalpha, ERalpha,ERbeta,N-CoR, SRC-1, SMRT and EGFR in rat was significantly increased in postlactating mammary gland when compared to that of nonlactating mammary tissue. Postlactating mammary glands were found to express all RAR and RXR subtypes studied when compared to nonlactating mammary tissues that express exclusively RARalpha and RXRalpha subtypes. Enhanced expression of a number of nuclear hormone receptors, their coregulators in mammary tissue of postlactating rats in comparison with nonlactating animals identify a potential role for retinoid, thyroid and estrogen signalling pathways also after lactation period.     

Isolation and characterization of a novel 39 kilodalton whey protein from bovine mammary secretions collected during the nonlactating period

A 39 kilodalton glycoprotein has been isolated from bovine mammary secretions by heparin-agarose affinity chromatography and gel filtration. It is a minor whey protein in mammary secretions collected during the nonlactating period, but is clearly detectable by affinity chromatographic and immunoblotting techniques. It is not detectable by these techniques in milk or colostrum. This protein is not immunologically related to milk proteins, serum proteins or cytoskeletal proteins. The N-terminal amino acid sequence (36 amino acids) is not similar to other known proteins. Isolating this novel 39 kilodalton protein provides a specific marker for mammary function during the nonlactating period.     

β-casein gene expression by in vitro cultured bovine mammary epithelial cells derived from developing mammary glands

Epithelial cells from mammary gland tissue that are cultured in vitro are able to maintain specific functions of this gland, such as cellular differentiation and milk protein synthesis. These characteristics make these cells a useful model to study mammary gland physiology, development and differentiation; they can also be used for production of exogenous proteins of pharmaceutical interest. Bovine mammary epithelial cells were cultured in vitro after isolation from mammary gland tissue of animals at different stages of development. The cells were plated on Petri dishes and isolated from fibroblasts using saline/EDTA treatment, followed by trypsinization. Cells isolated on plastic were capable of differentiating into alveolus-like structures; however, only cells derived from non-pregnant and non-lactating animals expressed β-casein. Real-time qPCR and epifluorescence microscopy analyses revealed that alveolus-like structures were competent at expressing Emerald green fluorescent protein (EmGFP) driven by the β-casein promoter, independent of β-casein expression.     

Evidence for the absence of the terminal adenine nucleotide at the amino acid-acceptor end of transfer ribonucleic acid in non-lactating bovine mammary gland and its inhibitory effect on the aminoacylation of rat liver transfer ribonucleic acid

1. tRNA isolated from non-lactating bovine mammary gland competitively inhibits the formation of aminoacyl-tRNA in the rat liver system. 2. Non-lactating bovine mammary gland tRNA and twice-pyrophosphorolysed rat liver tRNA are unable to accept amino acids in a reaction catalysed by aminoacyl-tRNA synthetases from either rat liver or bovine mammary gland. Deacylated rat liver tRNA can however be aminoacylated in the presence of either enzyme. 3. Bovine mammary gland tRNA lacks the terminal adenine nucleotide at the 3′-terminus amino acid acceptor end, which can be replaced by incubation in the presence of rat liver nucleotide-incorporating enzyme, ATP and CTP. 4. The enzymically modified bovine tRNA (tRNApCpCpA) can bind labelled amino acids to form aminoacyl-tRNA, which can then transfer its labelled amino acids to growing polypeptide chains on ribosomes. 5. Molecules of rat liver tRNA or bovine mammary gland tRNA that lack the terminal adenine nucleotide or the terminal cytosine and adenine nucleotides inhibit the aminoacylation of normal rat liver tRNA to varying degrees. tRNA molecules lacking the terminal −pCpCpA nucleotide sequence exhibit the major inhibitory effect. 6. The enzyme fraction from bovine mammary gland corresponding to that containing the nucleotide-incorporating enzyme in rat liver is unable to catalyse the incorporation of cytosine and adenine nucleotides in pyrophosphorolysed rat liver tRNA and deacylated bovine tRNA. This fraction also markedly inhibits the action of the rat liver nucleotide-incorporating enzyme.